Tokyo, Feb. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060522) titled 'Evaluation of an Oral Care Method Using a Moisture-Permeable Oral Care Gel' on Feb. 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Southern Tohoku General Hospital
Condition:
Condition - Patients in the acute hospital
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study evaluates the effects of using a highly permeable oral care gel on improving work efficiency in oral care for hospitalized patients and maintaining oral mucosal hydration.
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - Highly permeable oral moisturizer
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Study Population
Hospitalized patients with poor oral hygiene who were determined to require oral care and exhibited oral eschar.
Eligibility Criteria
(1) Aged 20 years or older
(2) Patients for whom oral care was requested by the attending physician
(3) Presence of oral eschar at the time of the initial oral care intervention by the oral surgeon
Key exclusion criteria - Exclusion Criteria
(1)Significantly unstable respiratory or circulatory status
(2) Inability to maintain an open mouth position
(3) Significant difficulty performing oral care involving instrument contact due to oral mucosal disease
(4) Presence of significant pain
Target Size - 10
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2024 Year 12 Month 26 Day
Date of IRB - 2024 Year 12 Month 26 Day
Anticipated trial start date - 2024 Year 12 Month 26 Day
Last follow-up date - 2026 Year 12 Month 25 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069236
Disclaimer: Curated by HT Syndication.